As of 28 Aug 2026, Curis Lifesciences Ltd share price is ₹124.95. The stock opened at ₹124.95 and had closed at ₹125.60 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹83.60 and a high of ₹147.90. In terms of performance, Curis Lifesciences Ltd share price has increased by 34.43% over the past six months and has decreased by 11.38% over the last year.
CURIS Charts
Curis Lifesciences Ltd Overview
About CURIS
Curis Lifesciences is the pharma manufacturer, specializing in manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral Liquid, Sterile Ophthalmic Ointments.
Curis Lifesciences Ltd Historical Performance
Curis Lifesciences Ltd Fundamental Analysis
Curis Lifesciences Ltd Financials
| Indicator | Sep 25 | Jun 25 |
|---|---|---|
| Revenue | - | 19.50 |
| EBITDA | - | 4.24 |
| Net Profit | 1.34 | 2.87 |
| EPS | 2.26 | 4.84 |
Curis Lifesciences Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 67.53 |
| MACD | 4.21 |
| 20-Day SMA | 113.47 |
Curis Lifesciences Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Curis Lifesciences Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Curis Lifesciences Ltd today is ₹124.95 on NSE and ₹124.95 on BSE.
- The 52-week high of Curis Lifesciences Ltd is ₹147.90, while the 52-week low is ₹83.60.
- The current market capitalisation of Curis Lifesciences Ltd is approximately ₹101 crore.
- The P/E (Price-to-Earnings) ratio of Curis Lifesciences Ltd is 14.51. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Curis Lifesciences Ltd is 2.08. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Curis Lifesciences Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Curis Lifesciences Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Curis Lifesciences Ltd has delivered a return of approximately N/A. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Curis Lifesciences Ltd comprises different categories of shareholders. As of Mar 2026, the shareholding is approximately 68.03% promoters, 1.19% FIIs, 5.80% DIIs, and 14.38% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
